Endothelin-1 (11-21)

CAS No. 144602-02-8

Endothelin-1 (11-21)( ——— )

Catalog No. M41119 CAS No. 144602-02-8

IRL 1038 is an endothelin B receptor selective antagonist with a Ki of 6-11 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Endothelin-1 (11-21)
  • Note
    Research use only, not for human use.
  • Brief Description
    IRL 1038 is an endothelin B receptor selective antagonist with a Ki of 6-11 nM.
  • Description
    ETB endothelin receptor antagonist
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    GPCR/G Protein
  • Target
    Endothelin Receptor
  • Recptor
    ETB endothelin receptor
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    144602-02-8
  • Formula Weight
    1409.67
  • Molecular Formula
    C68H92N14O15S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Urade Y, et al. An endothelin B receptor-selective antagonist: IRL 1038, Cys11-Cys15-endothelin-1(11-21). FEBS Lett. 1992 Oct 12;311(1):12-6. doi: 10.1016/0014-5793(92)81355-p.?
molnova catalog
related products
  • Enrasentan

    Enrasentan (sb-217242) is a mixed antagonist of ET(A) and ET(B) receptors that reduces blood pressure, prevents cardiac hypertrophy, and protects myocardial function.

  • BQ-788

    BQ-788 is a selective and potent ETB receptor antagonist with potential hypertensive activity.BQ-788 inhibits ET-1 binding to ETB receptors and inhibits exogenous ET-1-induced elevation of coronary artery perfusion pressure.

  • Sarafotoxin S6c

    Highly selective ETB endothelin receptor agonist (Ki values are 0.29 and 28000 nM at ETB and ETA receptors respectively).